ccfDNA In the Lab: Optimizing Purification for Sequencing (Part 3)
About This Webcast
ccfDNA Webinar Series: The Basics and Beyond Part 3 - ccfDNA In the Lab: Optimizing Purification for Sequencing Circulating Cell-free DNA can be used to monitor tumor burden and monitor disease progress. In this webinar, Dr. Gulley discusses variables important to isolating high-quality ccfDNA from plasma samples including anticoagulant, plasma volume and storage length and conditions. Have you seen the first 2 parts of the series? Part 1 - ccfDNA 101: Emerging Trends in Oncology Research Part 2 - ccfDNA Workflows: Honing in on the Target
Speakers
Margaret Gulley, MD
Professor and Director of Molecular Pathology , University of North Carolina-Chapel Hill
Margaret L. Gulley MD is professor and Director of Molecular Pathology in the Department of Pathology and Laboratory Medicine at University of North Carolina at Chapel Hill, USA. She provides laboratory services to patients with cancer, heritable disease, infectious disease, or transplant. Dr. Gulley’s research on virus-related malignancy seeks to validate novel molecular assays that add value for disease classification and monitoring. Work with professional societies aims to promote high quality molecular services in clinical laboratories.